Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (71-80 of 546) with videos related to

Pageof 55
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 23, 2011
A universally applicable 68Ga-labeling technique for proteinsCarmen Wängler, Björn Wängler, Sebastian Lehner, et al.
Oral Oncology|January 3, 2003
Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinomaMartin Kunkel, Gregor J Förster, Torsten E Reichert, et al.
Bioconjugate Chemistry|March 16, 2006
Synthesis and in vitro evaluation of biotinylated RG108: a high affinity compound for studying binding interactions with human DNA methyltransferasesEsther Schirrmacher, Carmen Beck, Bodo Brueckner, et al.
Neuroimage. Clinical|November 29, 2013
Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjectsMichael Ewers, Matthias Brendel, Angela Rizk-Jackson, et al.
Dementia and Geriatric Cognitive Disorders|September 18, 2010
Cerebrospinal fluid tau protein levels and 18F-fluorodeoxyglucose positron emission tomography in the differential diagnosis of Alzheimer's diseaseIgor Yakushev, Peter Bartenstein, Thomas Siessmeier, et al.
Synapse (New York, N.Y.)|March 26, 2010
α2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouseAxel Rominger, Erik Mille, Guido Böning, et al.
Human Brain Mapping|November 30, 2006
'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigationIngo Vernaleken, Hans-Georg Buchholz, Yoshitaka Kumakura, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
Peptide Receptor Radionuclide Therapy Using <sup>90</sup>Y- and <sup>177</sup>Lu-DOTATATE Modulating Atherosclerotic Plaque Inflammation: Longitudinal Monitoring by <sup>68</sup>Ga-DOTATATE Positron Emissions Tomography/Computer TomographyGerman Rubinstein, Harun Ilhan, Peter Bartenstein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2013
Positron emission tomography based in-vivo imaging of early phase stem cell retention after intramyocardial delivery in the mouse modelCajetan Lang, Sebastian Lehner, Andrei Todica, et al.
Molecular Imaging and Biology|March 21, 2015
The Influence of Early Measurements Onto the Estimated Kidney Dose in [(177)Lu][DOTA(0),Tyr(3)]Octreotate Peptide Receptor Radiotherapy of Neuroendocrine TumorsAndreas Delker, Harun Ilhan, Christian Zach, et al.
Pageof 55

Showing results (71-80 of 546) with videos related to

Sort By:
Pageof 55
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 23, 2011
A universally applicable 68Ga-labeling technique for proteinsCarmen Wängler, Björn Wängler, Sebastian Lehner, et al.
Oral Oncology|January 3, 2003
Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinomaMartin Kunkel, Gregor J Förster, Torsten E Reichert, et al.
Bioconjugate Chemistry|March 16, 2006
Synthesis and in vitro evaluation of biotinylated RG108: a high affinity compound for studying binding interactions with human DNA methyltransferasesEsther Schirrmacher, Carmen Beck, Bodo Brueckner, et al.
Neuroimage. Clinical|November 29, 2013
Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjectsMichael Ewers, Matthias Brendel, Angela Rizk-Jackson, et al.
Dementia and Geriatric Cognitive Disorders|September 18, 2010
Cerebrospinal fluid tau protein levels and 18F-fluorodeoxyglucose positron emission tomography in the differential diagnosis of Alzheimer's diseaseIgor Yakushev, Peter Bartenstein, Thomas Siessmeier, et al.
Synapse (New York, N.Y.)|March 26, 2010
α2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouseAxel Rominger, Erik Mille, Guido Böning, et al.
Human Brain Mapping|November 30, 2006
'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigationIngo Vernaleken, Hans-Georg Buchholz, Yoshitaka Kumakura, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
Peptide Receptor Radionuclide Therapy Using <sup>90</sup>Y- and <sup>177</sup>Lu-DOTATATE Modulating Atherosclerotic Plaque Inflammation: Longitudinal Monitoring by <sup>68</sup>Ga-DOTATATE Positron Emissions Tomography/Computer TomographyGerman Rubinstein, Harun Ilhan, Peter Bartenstein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2013
Positron emission tomography based in-vivo imaging of early phase stem cell retention after intramyocardial delivery in the mouse modelCajetan Lang, Sebastian Lehner, Andrei Todica, et al.
Molecular Imaging and Biology|March 21, 2015
The Influence of Early Measurements Onto the Estimated Kidney Dose in [(177)Lu][DOTA(0),Tyr(3)]Octreotate Peptide Receptor Radiotherapy of Neuroendocrine TumorsAndreas Delker, Harun Ilhan, Christian Zach, et al.
Pageof 55